Related Party Transactions

9 Months Ended

Sep. 30, 2021

Related Party Transactions [Abstract]

Related Party Transactions

Note 11. Related Party Transactions

During the year ended December 31, 2019, A2A Pharmaceuticals and Biomea Health, LLC invested a combined $1.4 million in the Company in exchange for 4,428,500 shares of the Company’s common stock. Biomea Health, LLC’s initial investment of $0.2 million was in the form of expenses paid by Biomea Health, LLC on behalf of the Company. During the nine months ended September 30, 2021, A2A Pharmaceuticals and Biomea Health, LLC invested a combined $0.3 million in the Company in exchange for 799,569 shares of the Company’s common stock. As of September 30, 2021 and December 31, 2020, the Company had an outstanding receivable balance from Biomea Health LLC of approximately $0 and $8,000, respectively. This receivable balance as of December 31, 2020 is related to operating expenses paid for by the Company on behalf of Biomea Health LLC.